While Pharvaris NV has overperformed by 5.71%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, PHVS rose by 44.76%, with highs and lows ranging from $29.80 to $11.51, whereas the simple moving average jumped by 34.84% in the last 200 days.
On October 15, 2025, H.C. Wainwright started tracking Pharvaris NV (NASDAQ: PHVS) recommending Buy. A report published by BofA Securities on October 09, 2025, Upgraded its rating to ‘Neutral’ for PHVS. Guggenheim also rated PHVS shares as ‘Buy’, setting a target price of $32 on the company’s shares in an initiating report dated June 11, 2025. Cantor Fitzgerald Initiated an Overweight rating on April 29, 2025, and assigned a price target of $28. Wedbush initiated its ‘Outperform’ rating for PHVS, as published in its report on September 25, 2023. Morgan Stanley’s report from August 15, 2023 suggests a price prediction of $34 for PHVS shares, giving the stock a ‘Overweight’ rating. Bryan Garnier also rated the stock as ‘Buy’.
Analysis of Pharvaris NV (PHVS)
To gain a thorough understanding of Pharvaris NV’s future performance, several well-rounded types of analysis and research techniques can be used, with equity being among the most crucial. The goal here is to ensure that your current return on equity of -51.81% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 12.86, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.
It is also very valuable to look at average volume as an indicator of volatility for a stock, and PHVS is recording an average volume of 327.67K. On a monthly basis, the volatility of the stock is set at 6.80%, whereas on a weekly basis, it is put at 3.60%, with a gain of 7.35% over the past seven days. Furthermore, long-term investors anticipate a median target price of $46.29, showing growth from the present price of $27.75, which can serve as yet another indication of whether PHVS is worth investing in or should be passed over.
How Do You Analyze Pharvaris NV Shares?
The number of employees owning shares of the company should also be considered in addition to the fundamentals. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 58.96%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 42.25% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.
